Psoriasis Studies are pretty much wrapped up they will need to submit other studies to the USA for FDA approval, Since there market is for the EU/UK as of now, these other ongoing test are on other skin disorders not psoriasis .
You are confusing between studies This is referring to preclinical study and to the announcement that was issued on 02/2017. Results for PRE clinical efficacy are already out - up to 70% improvement Product readiness depends on safety study that already started
The answer to the question is at the end of the sentence. I'll highlight in bold & red.
March 21 OWCP said: "As a result of the promising results of our psoriasis tests, our Chairman and CEO, Mr. Mordechai Bignitz, has directed OWC's scientific team to submit an operating plan within 60 to 90 days to conduct double-blind efficacy tests of our cannabinoid-based topical cream on other skin disorders and conditions."